AngioDynamics, Inc. (ANGO) Net margin 2017–2026
AngioDynamics, Inc. (ANGO) net profit margin by fiscal year — reported net income divided by reported revenue.
-11.5%FY2026 · since FY2017: 1.9% → -11.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -11.5% | +0.1 pp |
| FY2025 | -11.6% | +49.0 pp |
| FY2024 | -60.7% | -45.2 pp |
| FY2023 | -15.5% | -7.1 pp |
| FY2022 | -8.4% | +2.4 pp |
| FY2021 | -10.8% | +52.3 pp |
| FY2020 | -63.1% | -85.8 pp |
| FY2019 | 22.7% | +16.4 pp |
| FY2018 | 6.2% | +4.4 pp |
| FY2017 | 1.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice